Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00292266
What this trial is testing

Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
EMD Serono 677
Early research (Phase 1)Study completedNCT00306202
What this trial is testing

Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia

Who this might be right for
Leukemia
Bristol-Myers Squibb 63
Testing effectiveness (Phase 2)Looking for participantsNCT06193902
What this trial is testing

LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours.

Who this might be right for
Tumor, Solid
Leucid Bio 17
Testing effectiveness (Phase 2)Study completedNCT01462253
What this trial is testing

Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults

Who this might be right for
Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 35
Testing effectiveness (Phase 2)UnknownNCT00961077
What this trial is testing

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

Who this might be right for
ElderlyS-1Oxaliplatin+2 more
Soonchunhyang University Hospital 36
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Testing effectiveness (Phase 2)Study completedNCT01720875
What this trial is testing

Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)

Who this might be right for
Multiple Myeloma
University of Leeds 16
Not applicableNo Longer AvailableNCT02368301
What this trial is testing

Expanded Access Treatment Protocol CA204-143

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT07227311
What this trial is testing

Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 200
Not applicableUnknownNCT06450145
What this trial is testing

Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL

Who this might be right for
Tumour
Zhejiang Provincial People's Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02113319
What this trial is testing

Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
University Hospital, Angers 27
Testing effectiveness (Phase 2)Ended earlyNCT03547700
What this trial is testing

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Lymphoma, T-Cell, Peripheral
University of Michigan Rogel Cancer Center 11
Early research (Phase 1)Ended earlyNCT05098405
What this trial is testing

First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Molecular Partners AG 46
Testing effectiveness (Phase 2)UnknownNCT03156101
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects

Who this might be right for
Relapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic LeukemiaRelapsed／Refractory B-cell Lymphoma
Shenzhen BinDeBio Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Testing effectiveness (Phase 2)Looking for participantsNCT04047641
What this trial is testing

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaBlasts 20 Percent or More of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+5 more
M.D. Anderson Cancer Center 80
Not applicableActive Not RecruitingNCT01492751
What this trial is testing

Effectiveness of Localized Prostate Cancer Treatments

Who this might be right for
Prostate Cancer
Fundacion IMIM 500
Early research (Phase 1)Study completedNCT04855929
What this trial is testing

A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

Who this might be right for
Advanced Solid TumorAdult DiseaseLung Cancer
Anaveon AG 55
Testing effectiveness (Phase 2)Study completedNCT06083753
What this trial is testing

Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Janssen Research & Development, LLC 182
Large-scale testing (Phase 3)Looking for participantsNCT07071337
What this trial is testing

SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy

Who this might be right for
Metastatic Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430
Next Page